BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2159339)

  • 1. Sequence-specific 1H NMR assignments and secondary structure of eglin c.
    Hyberts SG; Wagner G
    Biochemistry; 1990 Feb; 29(6):1465-74. PubMed ID: 2159339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures.
    Hyberts SG; Goldberg MS; Havel TF; Wagner G
    Protein Sci; 1992 Jun; 1(6):736-51. PubMed ID: 1304915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation.
    Heinz DW; Hyberts SG; Peng JW; Priestle JP; Wagner G; Grütter MG
    Biochemistry; 1992 Sep; 31(37):8755-66. PubMed ID: 1390662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
    Bode W; Papamokos E; Musil D
    Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg.
    McPhalen CA; Schnebli HP; James MN
    FEBS Lett; 1985 Aug; 188(1):55-8. PubMed ID: 3926539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content.
    Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG
    J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.
    Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG
    J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional NMR studies of Kazal proteinase inhibitors. 1. Sequence-specific assignments and secondary structure of turkey ovomucoid third domain.
    Robertson AD; Westler WM; Markley JL
    Biochemistry; 1988 Apr; 27(7):2519-29. PubMed ID: 3164216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution.
    Hipler K; Priestle JP; Rahuel J; Grütter MG
    FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin.
    Bode W; Papamokos E; Musil D; Seemueller U; Fritz H
    EMBO J; 1986 Apr; 5(4):813-8. PubMed ID: 3519213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
    Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
    FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the spectral densities of N-H bond motions in eglin c using heteronuclear relaxation experiments.
    Peng JW; Wagner G
    Biochemistry; 1992 Sep; 31(36):8571-86. PubMed ID: 1390643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active site binding loop stabilization in the subtilisin inhibitor eglin c: structural and functional studies on specifically designed mutants in complex with subtilisin and the uncomplexed inhibitor.
    Hipler K; Priestle JP; Rahuel J; Grütter MG
    Adv Exp Med Biol; 1996; 379():43-7. PubMed ID: 8796309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton NMR assignments and secondary structure of the snake venom protein echistatin.
    Chen Y; Pitzenberger SM; Garsky VM; Lumma PK; Sanyal G; Baum J
    Biochemistry; 1991 Dec; 30(50):11625-36. PubMed ID: 1661142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.
    Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M
    J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P; Teplyakov AV; Hol WG
    Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1H NMR probe for mobility in the reactive center loops of serpins: spin-echo studies of native and modified forms of ovalbumin and alpha 1-proteinase inhibitor.
    Hood DB; Gettins P
    Biochemistry; 1991 Sep; 30(37):9054-60. PubMed ID: 1892818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific assignments of side-chain protons and characterization of torsion angles in Eglin c.
    Hyberts SG; Märki W; Wagner G
    Eur J Biochem; 1987 May; 164(3):625-35. PubMed ID: 3032625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C.
    Dauter Z; Betzel C; Genov N; Pipon N; Wilson KS
    Acta Crystallogr B; 1991 Oct; 47 ( Pt 5)():707-30. PubMed ID: 1793542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.